tgtx stock price guide

TGTX stock price

Brief description

The term "tgtx stock price" refers to the market price of shares of TG Therapeutics, Inc., listed under the ticker TGTX on NASDAQ. This guide explains the company background, how the tgtx stock price has behaved historically, the common drivers that move its shares, valuation and trading metrics investors and traders use, and where to obtain real‑time quotes and downloadable historical data. Readers will learn which sources publish live or delayed quotes, how clinical and regulatory news typically affects tgtx stock price, and practical next steps for monitoring the ticker. For execution or custody, consider trading via Bitget and storing crypto‑linked assets in Bitget Wallet when applicable.

As of 2026-01-27, according to MarketWatch and the TG Therapeutics investor relations site, up‑to‑date intraday quotes and historical closing prices are available through major data providers; always verify whether a feed is real‑time or delayed before making time‑sensitive decisions.

Company overview

TG Therapeutics, Inc. is a biopharmaceutical company focused on therapies for B‑cell malignancies and autoimmune diseases. The firm develops and commercializes treatments that target B‑cell pathways; its commercial portfolio has included products such as BRIUMVI and pipeline programs spanning multiple clinical stages. Founded in the 2010s and headquartered in New York (corporate filings list the registered headquarters), TG Therapeutics has a development strategy that combines in‑house research with strategic collaborations and licensing arrangements.

Understanding the business model and product pipeline is useful because the tgtx stock price is highly sensitive to clinical readouts, regulatory approvals, commercial adoption of marketed therapies, and partnership announcements. As a clinical‑stage and commercial company, TG Therapeutics’ fundamentals mix product revenue potential with binary regulatory risk inherent to biotech firms.

Ticker and listing information

• Ticker symbol: TGTX (commonly presented in uppercase on exchange screens).
• Primary exchange: NASDAQ (U.S. exchange where TGTX is listed).
• Identifiers: Standard security identifiers such as ISIN and FIGI are assigned to TG Therapeutics securities; these can be found in the company’s SEC filings or data provider pages.
• Trading hours: Regular NASDAQ trading hours apply for TGTX (U.S. market hours). Extended‑hours quotes (pre‑market and after‑hours) may be displayed separately by data vendors; note that volume and spreads can differ materially in extended sessions.

Data providers may display the ticker slightly differently (for example, some platforms prefix exchange codes), but searching for TGTX on major quote screens will surface the same underlying security. When looking for live execution, confirm your broker or exchange feed offers real‑time NASDAQ data.

Historical price performance

A multi‑year view of the tgtx stock price shows episodic volatility typical of biotech companies. Over medium and long horizons, share performance often reflects the timing and outcomes of clinical trials, regulatory milestones, licensing deals and product launches. Notable historical milestones that have historically driven large moves include late‑stage clinical readouts, FDA regulatory decisions, and major corporate announcements.

Common reference points investors use: multi‑year percentage return, annualized volatility, and the 52‑week high and low. Detailed day‑by‑day historical closing data and corporate action‑adjusted series are available from the company’s investor relations historic lookup and from data vendors such as Yahoo Finance, MarketWatch, TradingView and Barchart.

Recent price movements and catalysts

Near‑term price changes in the tgtx stock price are frequently driven by a set of repeatable catalyst types. Examples include:

• Clinical trial announcements and readouts (positive efficacy or safety data typically lifting the stock; adverse results can cause sharp declines).
• Regulatory news, including NDA/BLA submissions, FDA actions, advisory committee meetings and label decisions.
• Quarterly earnings and revenue guidance changes.
• Commercial news: launch metrics, payer coverage, or partnership and supply agreements.
• Analyst reports, upgrades, downgrades and changes in price targets.
• Broader sector or market sentiment shifts affecting biotech multiples.

As of 2026-01-27, according to public filings and major business news outlets, routine press releases and SEC filings remain primary sources for corporate news that affects tgtx stock price. Market commentary from specialized biotech analysts often amplifies reactions to these events.

Earnings and financial results

Quarterly earnings reports and management guidance are central to how the tgtx stock price reacts to fundamentals. Revenue beats, higher‑than‑expected guidance, or notable changes to cost structure can support share prices; conversely, revenue misses, worsening margins, or downbeat guidance can pressure the stock. Earnings summary pages on platforms such as Yahoo Finance, CNN Markets and Morningstar provide earnings calendars, consensus estimates and historical results that help contextualize price moves.

Investors watching the tgtx stock price often track: reported revenues, R&D and SG&A expenses, cash runway, and any commentary from management about commercial uptake of marketed therapies or near‑term trial milestones.

Regulatory and clinical news

Because TG Therapeutics operates in the drug development space, regulatory and clinical developments are among the strongest single‑event drivers of the tgtx stock price. Examples of catalyst reactions include:

• FDA approval of a new indication or product, which can create large positive revisions to revenue expectations.
• Complete response letters or negative advisory opinions, which can cause rapid selloffs.
• Mid‑stage or pivotal trial readouts, where interim safety or efficacy data change the probability of future approval.

Clinical and regulatory updates often create short‑term volatility as markets re‑price the probability of future commercial success. For reliable updates, consult the company’s official press releases and SEC filings, supplemented by specialized biotech reporting from financial data vendors.

Valuation metrics and fundamentals

Common metrics used to evaluate the tgtx stock price include:

• Market capitalization — the aggregate equity value at the current price.
• Price‑to‑earnings (P/E) ratio — when the company reports positive earnings; many clinical‑stage or newly commercial biotech firms will lack a meaningful P/E, so alternative metrics are used.
• Price‑to‑sales (P/S) ratio — useful when revenue is present but earnings are negative.
• Enterprise value and EV/Revenue or EV/EBITDA — for cross‑company comparisons.
• Cash on hand and burn rate — critical for assessing runway and dilution risk.

Up‑to‑date figures for market cap, trailing multiples, margins and balance sheet items can be found on Morningstar, Yahoo Finance, TradingView and company SEC filings. When assessing the tgtx stock price, compare multiple valuation metrics and the firm’s clinical development timeline to determine whether market pricing reflects realistic commercialization scenarios.

Trading characteristics

Trading characteristics that influence the tgtx stock price intraday and over longer horizons include average daily volume, shares outstanding and float, short interest, and historical volatility. For many biotech tickers, relatively concentrated float or elevated short interest can amplify price moves around news events.

• Average daily volume provides a sense of typical liquidity — low volume can lead to wider spreads and more pronounced intraday swings.
• Float and shares outstanding determine how much buying or selling pressure is required to move the price.
• Volatility and beta show how much tgtx stock price typically moves relative to the broader market.

Platforms such as Robinhood (quote pages), Barchart and TradingView publish trading statistics that traders use to calibrate position sizing and risk. Community platforms like Stocktwits additionally provide crowd sentiment that sometimes correlates with short‑term volume spikes.

Technical analysis and market sentiment

Traders following the tgtx stock price often reference standard technical indicators and chart patterns:

• Moving averages (20‑day, 50‑day, 200‑day) to identify trend direction and crossovers.
• Support and resistance levels derived from historical highs and lows.
• Chart patterns such as flags, double tops/bottoms, and breakouts that traders interpret as potential continuation or reversal signals.
• Momentum indicators (RSI, MACD) to gauge overbought or oversold conditions.

Market sentiment and idea flow appear on discussion platforms like Stocktwits and TradingView, where traders publish charts and theses. These communities can amplify short‑term moves; monitoring sentiment alongside volume and order flow provides a more complete picture of why the tgtx stock price may be moving.

Analyst coverage and price targets

Analyst coverage matters for the tgtx stock price because upgrades, downgrades and revised price targets can change demand dynamics and media narratives. Data aggregators such as Yahoo Finance and Morningstar compile consensus ratings, the number of covering analysts, and average price targets.

When an analyst upgrades their rating or raises the price target citing stronger trial data or commercial traction, markets may respond with renewed buying. The reverse holds for downgrades or target cuts. Tracking broker reports and regulatory filings helps explain sharp moves in the tgtx stock price.

Historical data, charts and resources

For reliable historical data and charts of the tgtx stock price, consult the following types of sources: company investor relations historic lookup (provides official share history and corporate actions), financial portals with downloadable CSVs (Yahoo Finance, MarketWatch, Barchart), and charting platforms (TradingView) that support intraday and multi‑timeframe analysis.

Many vendors allow users to export time series for backtesting or record‑keeping. Remember to use corporate action‑adjusted series (which account for splits and dividends) when performing long‑term return calculations.

How to find real‑time TGTX prices

Practical guidance for real‑time or near‑real‑time quotes of the tgtx stock price:

• Confirm whether a data provider supplies real‑time NASDAQ feeds or delayed quotes (many free services have a 15‑minute delay).
• For live trading, use a broker or exchange that provides real‑time market data for NASDAQ securities.
• Trusted sources for quotes and charts include MarketWatch, Yahoo Finance, TradingView, Barchart and the company investor relations page. Community platforms like Stocktwits and TradingView offer idea flow but not guaranteed real‑time execution prices.

If you plan to trade, ensure your execution venue (e.g., Bitget for supported equity products in your jurisdiction) is authorized for equities and provides the necessary market data subscriptions. For custody of crypto assets or Web3 wallets related to biotech tokenization projects, consider Bitget Wallet as a recommended option for on‑chain asset management.

Corporate actions, dividends and splits

Corporate actions such as share splits, reverse splits, dividends, or mergers affect historical price series and per‑share metrics. Vendors typically publish price series adjusted for these events; always check the adjustment notes when comparing historical prices.

Official records of corporate actions are available from the company’s investor relations page and in SEC filings. When working with historical tgtx stock price data for performance calculations, use adjusted close values to avoid misleading results.

Risks and considerations for investors

Key risks that can materially affect the tgtx stock price include:

• Clinical and regulatory risk: trial failures, safety concerns, or negative regulatory decisions can produce sharp downside.
• Commercial risk: slower than expected uptake, limited payer coverage, or competitive products can reduce revenue prospects.
• Biotech sector volatility: sector‑wide repricing events can drag down tgtx along with peers.
• Financing and dilution risk: the company may need to raise capital, which can dilute existing shareholders.
• Liquidity and market microstructure: low liquidity or concentrated holdings can amplify price moves.

This guide is informational and not investment advice. Always consult multiple primary sources — official filings, company press releases and registered broker research — before taking action.

See also

• TG Therapeutics (company profile)
• List of biotechnology companies
• NASDAQ listing guide
• Common financial metrics explained (market cap, P/S, EV/EBITDA)
• Technical indicators primer (moving averages, RSI, MACD)

References and data sources

Primary sources and commonly used data vendors for the tgtx stock price and company information include:

• TG Therapeutics investor relations and SEC filings (corporate announcements, historic lookup and official filings)
• MarketWatch (TGTX quote and news)
• Yahoo Finance (TGTX overview, historical data and analyst estimates)
• TradingView (NASDAQ:TGTX charts and community ideas)
• Robinhood (TGTX quote pages and trading statistics)
• Stocktwits (community feed for TGTX)
• CNN Markets (earnings and market headlines)
• Barchart (historical data, volume and technicals)
• Morningstar (fundamentals and valuation metrics)

As of 2026-01-27, according to MarketWatch and company filings, up‑to‑date intraday prices, 52‑week ranges, and market cap figures are published on the above platforms. For precise numeric values such as current price, market capitalization and 52‑week high/low, consult these sources directly because live figures change continuously.

Further exploration and next steps

If you want to monitor the tgtx stock price in real time, add TGTX to your watchlist on a reliable charting platform and enable alerts for price levels or news. For execution and custody needs, consider using Bitget for trading (where supported) and Bitget Wallet to manage related on‑chain assets. For decisions that rely on numeric precision, always cross‑check the latest SEC filings, company press releases and exchange data feeds.

Sources: company investor relations, SEC filings, MarketWatch, Yahoo Finance, TradingView, Barchart, Morningstar, Stocktwits and CNN Markets (reporting dates vary by item; verify the timestamp on each source).